| Code | CSB-RA005934A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:1000-1:2000 |
| IHC | 1:100-1:200 |
| IF | 1:50-1:200 |
CD21, also known as complement receptor type 2 (CR2), plays a central role in both innate and adaptive immunity by serving as the receptor for complement C3d fragments and functioning as the primary cellular entry point for Epstein-Barr virus. This dual function makes CD21 a critical target for researchers investigating complement-mediated immune responses, B cell activation and signaling, and EBV-associated pathologies including certain lymphomas and autoimmune conditions.
This recombinant monoclonal antibody, generated from clone 16F10 in rabbit host, offers the reproducibility and consistency that demanding immunology research requires. Because the antibody sequence is defined and production occurs through recombinant expression rather than traditional hybridoma methods, you can expect reliable performance across experiments and minimal lot-to-lot variation, which is particularly valuable for longitudinal studies or multi-site collaborations.
Validation testing demonstrates robust performance across multiple applications using human samples. Western blot analysis of Raji whole cell lysate detects a band at the predicted molecular weight of 155 kDa, confirming target specificity in this well-characterized Burkitt lymphoma B cell line. Immunohistochemistry staining has been validated in paraffin-embedded human tonsil tissue and human lung cancer sections using citrate buffer antigen retrieval, providing flexibility for both normal and pathological tissue analysis. For cellular studies, immunofluorescence and flow cytometry applications have been successfully performed using Raji cells, enabling both qualitative localization and quantitative expression analysis.
The antibody's versatility across tissue sections, cell lysates, and intact cells makes it well-suited for comprehensive CD21 characterization in immunology research, particularly studies examining B cell biology, complement receptor function, and EBV-host interactions.
There are currently no reviews for this product.